In light of the World Health Organization's (WHO) declaration of mpox as a global public health emergency, the Indian government has escalated its efforts to preemptively address the potential spread of the virus within the country. Health Ministry sources have revealed that hospitals nationwide have been put on high alert, with strict instructions to identify patients presenting with rashes—one of the hallmark symptoms of mpox. To bolster the country’s readiness, isolation wards are being established in major healthcare facilities, ensuring that suspected cases can be quickly quarantined to prevent any potential outbreaks.
In the capital city of Delhi, three prominent hospitals—Safdarjung Hospital, Lady Hardinge Medical College, and Ram Manohar Lohia Hospital—have been designated as nodal centers specifically tasked with handling mpox cases. These hospitals are equipped to perform RT-PCR and nasal swab tests on patients suspected of carrying the virus, enabling prompt diagnosis and treatment. This strategic preparation is part of a broader nationwide effort to enhance the country’s healthcare infrastructure in response to the looming threat posed by the new mpox strain.
Airports across India have also been instructed to implement stringent screening measures for incoming passengers, particularly those arriving from regions where mpox cases have been reported. These measures include enhanced monitoring protocols and the potential isolation of travelers displaying symptoms consistent with mpox. The government’s proactive stance underscores its commitment to minimizing the risk of mpox entering and spreading within the country.
The recent spike in global mpox cases, including the detection of the virus in Pakistan and Sweden, has heightened concerns about its rapid transmission. The new strain of mpox is reportedly more virulent, with a higher propensity for spreading through close physical contact, including sexual interactions. This has led to increased vigilance among global health authorities, as the virus poses a significant public health challenge.
Although India has not yet recorded any cases of the new mpox strain, the government is not taking any chances. Historical data shows that from June 2022 to May 2023, India reported 30 cases of mpox, mostly among foreign nationals. This has led to heightened scrutiny of potential cases and an intensified focus on public health measures. Health officials have also noted that individuals who have received the smallpox vaccine may have immunity against mpox, reducing their risk of infection. At this stage, there is no immediate need for a specialized mpox vaccine for the general population, although this may change if the situation escalates.
The government’s comprehensive response strategy reflects its dedication to protecting public health. By mobilizing healthcare resources, enhancing airport surveillance, and ensuring that hospitals are prepared to handle potential cases, India is positioning itself to effectively manage and mitigate the impact of mpox should it enter the country. As the situation unfolds, the government remains vigilant, ready to adjust its strategies as necessary to ensure that India remains resilient in the face of this emerging global health threat.
Â
